Chronic Administration of Small Nonerythropoietic Peptide Sequence of Erythropoietin Effectively Ameliorates the Progression of Postmyocardial Infarction–Dilated Cardiomyopathy

The cardioprotective properties of erythropoietin (EPO) in preclinical studies are well documented, but erythropoietic and prothrombotic properties of EPO preclude its use in chronic heart failure (CHF). We tested the effect of long-term treatment with a small peptide sequence within the EPO molecul...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ahmet, Ismayil, Tae, Hyun-Jin, Brines, Michael, Cerami, Anthony, Lakatta, Edward G., Talan, Mark I.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The American Society for Pharmacology and Experimental Therapeutics 2013
Konular:
Drug Discovery and Translational Medicine
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3657107/
https://ncbi.nlm.nih.gov/pubmed/23584743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.113.202945
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller